[go: up one dir, main page]

BE903110A - Derives d'ethylenediaminemonoamide - Google Patents

Derives d'ethylenediaminemonoamide

Info

Publication number
BE903110A
BE903110A BE0/215498A BE215498A BE903110A BE 903110 A BE903110 A BE 903110A BE 0/215498 A BE0/215498 A BE 0/215498A BE 215498 A BE215498 A BE 215498A BE 903110 A BE903110 A BE 903110A
Authority
BE
Belgium
Prior art keywords
formula
ethylenediaminemonoamide
derivatives
monominooxidase
ethylenediaminemomoamides
Prior art date
Application number
BE0/215498A
Other languages
English (en)
Original Assignee
F Hoffmann La Roche Et Cie Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from CH4132/84A external-priority patent/CH661043A5/de
Priority claimed from CH2404/85A external-priority patent/CH664755A5/de
Application filed by F Hoffmann La Roche Et Cie Sa filed Critical F Hoffmann La Roche Et Cie Sa
Publication of BE903110A publication Critical patent/BE903110A/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/81—Amides; Imides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A61K9/2018—Sugars, or sugar alcohols, e.g. lactose, mannitol; Derivatives thereof, e.g. polysorbates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/78—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen, e.g. ester or nitrile radicals
    • C07D213/84—Nitriles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D241/00—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings
    • C07D241/02—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings
    • C07D241/06—Heterocyclic compounds containing 1,4-diazine or hydrogenated 1,4-diazine rings not condensed with other rings having one or two double bonds between ring members or between ring members and non-ring members
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D261/00—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/10—Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D261/18—Carbon atoms having three bonds to hetero atoms, with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D263/00—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings
    • C07D263/02—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings
    • C07D263/30—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D263/34—Heterocyclic compounds containing 1,3-oxazole or hydrogenated 1,3-oxazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D277/00—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/32—Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D277/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D307/56—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/68—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
    • C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
    • C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Psychiatry (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Pain & Pain Management (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Medicinal Preparation (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Hydrogenated Pyridines (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Pyrrole Compounds (AREA)

Abstract

Il a été constaté que les éthylènediaminemomoamides de formule I dans laquelle R représente un reste hétérocyclique aromatique penta-ou hexagonal tel qu'il est défini dans la revendication 1, ainsi que leurs sels d'addition avec des acides pharmaceutiquement utilisables présentent, à faible toxicité, d'intéressantes propriétés inhibitrices de la monominooxydase et peuvent par conséquent etre utilisées pour le traitement d'états dépressifs et de la maladie de Parkinson. A l'exception du N-(2-aminoéthyl) pyridine-2-carboxamide, tous les composés de formule I sont encore nouveaux; ils peuvent etre préparés selon des procédés connus.
BE0/215498A 1984-08-29 1985-08-23 Derives d'ethylenediaminemonoamide BE903110A (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CH4132/84A CH661043A5 (en) 1984-08-29 1984-08-29 Ethylenediamine monoamide derivatives
CH2404/85A CH664755A5 (de) 1985-06-05 1985-06-05 Aethylendiaminmonoamid-derivat.

Publications (1)

Publication Number Publication Date
BE903110A true BE903110A (fr) 1986-02-24

Family

ID=25690366

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/215498A BE903110A (fr) 1984-08-29 1985-08-23 Derives d'ethylenediaminemonoamide

Country Status (28)

Country Link
US (1) US4764522A (fr)
JP (2) JPH0764817B2 (fr)
KR (1) KR920007269B1 (fr)
AR (1) AR244209A1 (fr)
AT (1) AT391694B (fr)
AU (1) AU582381B2 (fr)
BE (1) BE903110A (fr)
BG (1) BG60401B1 (fr)
CA (1) CA1261335A (fr)
DE (1) DE3530046C2 (fr)
DK (1) DK162888C (fr)
ES (2) ES8705372A1 (fr)
FI (1) FI83511C (fr)
FR (1) FR2569694B1 (fr)
GB (1) GB2163746B (fr)
GR (1) GR852071B (fr)
HU (1) HU197309B (fr)
IE (1) IE58788B1 (fr)
IL (1) IL76176A (fr)
IT (1) IT1190385B (fr)
LU (1) LU86049A1 (fr)
MC (1) MC1696A1 (fr)
NL (1) NL193583C (fr)
NO (1) NO169711C (fr)
NZ (1) NZ213193A (fr)
PH (1) PH22813A (fr)
PT (1) PT81041B (fr)
SE (1) SE464083B (fr)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0352581A3 (fr) * 1988-07-28 1990-07-04 F. Hoffmann-La Roche Ag Dérivés d'éthylènediamine monoamide
US5204482A (en) * 1988-07-28 1993-04-20 Hoffman-Laroche Inc. Compounds for treating and preventing cognitive diseases and depression and methods of making same
CA2245055C (fr) * 1989-02-28 2003-03-25 F. Hoffmann-La Roche Ag Amidation des pyridines
EP0451790A1 (fr) * 1990-04-12 1991-10-16 Hoechst Aktiengesellschaft 2-isoxazolines et isoxazoles 3,5-disubstitués, procédé pour leur préparation,médicaments les contenant et leur utilisation
JPH04295470A (ja) * 1991-03-22 1992-10-20 Wakamoto Pharmaceut Co Ltd モノアミンオキシダーゼ−ｂ酵素阻害活性を有する１，２，４−オキサジアゾール誘導体及びその製造法
RU2097378C1 (ru) * 1991-03-26 1997-11-27 Ф.Хоффманн-Ля Рош Аг ПРОИЗВОДНЫЕ N-АЦИЛ- α -АМИНОКИСЛОТЫ ИЛИ ИХ ФИЗИОЛОГИЧЕСКИ ПРИЕМЛЕМЫЕ СОЛИ, ПРОСТЫЕ ИЛИ СЛОЖНЫЕ ЭФИРЫ, АМИДЫ ИЛИ ГИДРАТЫ И КОМПОЗИЦИЯ ИНГИБИРУЮЩАЯ СВЯЗЫВАНИЕ АДГЕЗИВНЫХ ПРОТЕИНОВ С ТРОМБОЦИТАМИ И АГРЕГАЦИЮ ТРОМБОЦИТОВ
US5545658A (en) * 1991-03-26 1996-08-13 Hoffman-La Roche Inc. Amino acid derivatives
FR2803592A1 (fr) * 2000-01-06 2001-07-13 Aventis Cropscience Sa Nouveaux derives de l'acide 3-hydroxypicolinique, leur procede de preparation et compositions fongicides les contenant.
JP2005524612A (ja) * 2001-12-06 2005-08-18 ファイブローゲン、インコーポレーテッド 内因性エリスロポエチン（ｅｐｏ）を増加させる方法
US6667327B2 (en) 2002-02-04 2003-12-23 Hoffmann-La Roche Inc. Pyridine amido derivatives
DE602004017206D1 (de) * 2003-10-23 2008-11-27 Hoffmann La Roche Benzazepin-derivate als mao-b-hemmer
WO2007008963A1 (fr) * 2005-07-13 2007-01-18 Jenrin Discovery Inhibiteurs de la mao-b utiles pour traiter l'obésité
WO2008010796A1 (fr) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Méthode de préparation de pyridine-2-carboxamides et de leurs intermédiaires
WO2008010794A1 (fr) * 2006-07-18 2008-01-24 Renaissance Medicine, Llc Préparations pharmaceutiques de lazabémide cristallin
FR2904317A1 (fr) * 2006-07-27 2008-02-01 Inst Nat Sante Rech Med Analogues d'halogenobenzamides marques a titre de radiopharmaceutiques
EP2085390A1 (fr) 2008-01-31 2009-08-05 Institut National De La Sante Et De La Recherche Medicale (Inserm) Analogues d'halobenzamide marqués en tant que produits radiopharmaceutiques multimodaux et leurs précurseurs
WO2011028740A1 (fr) * 2009-09-03 2011-03-10 Glaxo Group Limited Bloqueurs du canal enac
CA2914662C (fr) * 2013-06-13 2022-05-31 Robert Shalwitz Compositions et methodes de traitement de l'anemie
KR20240038132A (ko) 2015-04-01 2024-03-22 아케비아 테라퓨틱스 인코포레이티드 빈혈 치료용 조성물 및 방법
WO2019028150A1 (fr) 2017-08-01 2019-02-07 Akebia Therapeutics, Inc. Compositions destinées à être utilisées dans des méthodes de traitement des hémoglobinopathies

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB451304A (en) * 1934-07-07 1936-08-04 Karl Merck Process for the manufacture of new derivatives of pyrazinemonocarboxylic acid
NL300271A (fr) * 1962-11-09
NL6707566A (fr) * 1966-08-17 1968-02-19
GB1509527A (en) * 1974-06-05 1978-05-04 Ici Ltd 1-(aryl-or heteroaryl)oxy-3-(substituted-amino)propan-2-ol derivatives processes for their manufacture and pharmaceutical compositions containing them
US4041032A (en) * 1974-01-16 1977-08-09 Yamanouchi Pharmaceutical Co., Ltd. Pyrazine derivatives
GB1509300A (en) * 1975-12-05 1978-05-04 Ici Ltd Ethanolamine derivatives
DE3239573A1 (de) * 1981-10-28 1983-05-19 Byk Gulden Lomberg Chemische Fabrik Gmbh, 7750 Konstanz Substituierte picolinsaeuren, verfahren zu ihrer herstellung, ihre verwendung und sie enthaltende arzneimittel
IE54220B1 (en) * 1981-12-23 1989-07-19 Ici Plc Phenol esters
CH653670A5 (de) * 1983-03-03 1986-01-15 Hoffmann La Roche Benzamid-derivate.

Also Published As

Publication number Publication date
GR852071B (fr) 1985-12-24
FI83511B (fi) 1991-04-15
ES8800158A1 (es) 1987-11-01
SE464083B (sv) 1991-03-04
DK162888B (da) 1991-12-23
PH22813A (en) 1988-12-27
NL193583B (nl) 1999-11-01
NO169711B (no) 1992-04-21
DK391485D0 (da) 1985-08-28
AU582381B2 (en) 1989-03-23
HUT38317A (en) 1986-05-28
NL193583C (nl) 2000-03-02
GB2163746A (en) 1986-03-05
FR2569694A1 (fr) 1986-03-07
HU197309B (en) 1989-03-28
ES546482A0 (es) 1987-05-01
US4764522A (en) 1988-08-16
JPH0764817B2 (ja) 1995-07-12
PT81041A (en) 1985-09-01
BG96645A (bg) 1993-12-24
IT8521865A0 (it) 1985-08-05
SE8504014L (sv) 1986-03-01
JPH0825879B2 (ja) 1996-03-13
IE58788B1 (en) 1993-11-17
FI853140L (fi) 1986-03-01
NL8502374A (nl) 1986-03-17
GB2163746B (en) 1988-06-22
IL76176A0 (en) 1985-12-31
ES552399A0 (es) 1987-11-01
ES8705372A1 (es) 1987-05-01
FI83511C (fi) 1991-07-25
MC1696A1 (fr) 1986-07-18
DE3530046C2 (de) 1997-12-04
NZ213193A (en) 1989-10-27
GB8521358D0 (en) 1985-10-02
DK162888C (da) 1992-05-11
PT81041B (pt) 1988-01-22
AT391694B (de) 1990-11-12
NO169711C (no) 1992-07-29
JPH07300417A (ja) 1995-11-14
BG60401B1 (en) 1995-02-28
AR244209A1 (es) 1993-10-29
ATA251585A (de) 1990-05-15
IL76176A (en) 1989-02-28
AU4663685A (en) 1986-03-06
KR920007269B1 (ko) 1992-08-29
KR870002078A (ko) 1987-03-30
NO853390L (no) 1986-03-03
JPS6160657A (ja) 1986-03-28
CA1261335A (fr) 1989-09-26
IE852118L (en) 1986-02-28
LU86049A1 (de) 1986-09-11
FR2569694B1 (fr) 1991-05-03
DK391485A (da) 1986-03-01
SE8504014D0 (sv) 1985-08-28
IT1190385B (it) 1988-02-16
DE3530046A1 (de) 1986-03-13
FI853140A0 (fi) 1985-08-15

Similar Documents

Publication Publication Date Title
BE903110A (fr) Derives d'ethylenediaminemonoamide
TNSN97110A1 (fr) Derives de 2-(2-oxo-ethylidene)-imidazolidine-4-one, procede pour leur preparation et compositions pharmaceutiques les contenant
DE2827018A1 (de) Entzuendungshemmende, analgetische, gelierte salbe
TNSN96075A1 (fr) N-(indole-2-carbonyl) - beta- alaninamides substitues et leurs derives, servant d'agents antidiabetiques
FR2439187A1 (fr) Derives de 1-piperazine-carboxamides et -carbothioamides substitues, procede de preparation et compositions pharmaceutiques les contenant
CA2094137A1 (fr) Nouveau derive d'acide hydroxamique et de n-hydroxyuree; leur utilisation
TNSN98154A1 (fr) Derives de 2-aminopyridine nouveaux et compositions pharmaceutiques les contenant
TNSN98036A1 (fr) Derives d'acide hexanoique nouveaux
TNSN98083A1 (fr) Derives de 6-0 methylerythromycine a, procede pour leur preparation et compositions pharmaceutiques les contenant.
EP1004582A3 (fr) Composés de pyridazino quinoléine
IE50549B1 (en) Pharmaceutical compositions containing a corticosteroid substance
RU94042907A (ru) Производные имидазопиридина, способ их получения, фармацевтическая композиция и способ ее получения
TW200502221A (en) Novel lactams and uses thereof
BE899564A (fr) Composition pharmaceutique pour l'administration parenterale a base de nimodipin et procede pour sa preparation.
TNSN00235A1 (fr) Derives d'heterocyclo-alkylsulfonylpyrazole nouveaux, procede pour leur preparation et compositions les contenant
RU95111308A (ru) Производные 2-амино-4-фенил-4-оксомасляной кислоты, способы получения, фармацевтическая композиция
FR2426694A1 (fr) Cephalosporines perfectionnees, leur procede de preparation et leur application therapeutique
WO2009024348A1 (fr) Procédé d'activation de lymphocytes t régulateurs
TNSN99013A1 (fr) Derives d'acide dihydroxyhexanoique nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
TNSN98185A1 (fr) Derives d'isoquinoleine nouveaux, procede pour leur preparation et compositions pharmaceutiques les contenant
FI101377B1 (fi) Menetelmä N-alkyloitujen 1,4-dihydropyridiiniyhdisteiden valmistamiseksi
CA2140361A1 (fr) Composition et methodes pour diminuer l'affaissement musculaire
BE901301A (fr) 5-pyrimidine-carboxamides et thiocarboamides, ainsi que le traitement de la leucemie et des tumeurs avec ces substances.
DE69814089T2 (de) Verwendung von einem draflazin analog zur schmerzbehandlung
FR2392023A1 (fr) Nouveaux trans-5-aryl-2,3,4,4a,5,9,b-hexahydro-1h-pyrido (4,3-b) indoles, leur procede de preparation et composition pharmaceutique les contenant

Legal Events

Date Code Title Description
RE20 Patent expired

Owner name: F. *HOFFMANN-LA ROCHE A.G.

Effective date: 20050823

RE20 Patent expired

Owner name: F. *HOFFMANN-LA ROCHE A.G.

Effective date: 20050823